Signup Crypto ETF Stocks News

Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention

Derek Maetzold, CEO of Castle Biosciences, will participate in a panel discussion alongside other industry leaders during BIO 2025.

Source: www.globenewswire.com
June 11, 2025 | 11:00:00
Category: News

YY Group Expands Integrated Facility Management Portfolio with 24IFM Acquisition, Projects S$17.04 Million in Revenue from Singapore's Multi-Billion Dollar Market

Singapore , June 11, 2025 ( GLOBE NEWSWIRE ) -- YY Group Holding Limited ( NASDAQ: YYGH ) ( "YY Group," "YYGH," or the "Company" ) , a global leader in on-demand workforce solutions and integrated facility management ( IFM ) , is pleased to announce the assets acquisition of the Managing ...

Source: www.globenewswire.com
June 11, 2025 | 11:00:00
Category: News

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator ( PoNS® ) Device

-Aetna authorizes claim for PoNS Device at out-of-network negotiated price of $18,350, becoming the third payer to join Anthem and United in providing PoNS ...

Source: www.globenewswire.com
June 11, 2025 | 11:00:00
Category: News

Iterum Therapeutics Announces Partnership for Commercialization Services

U.S. Commercial Launch of ORLYNVAHTM by Q4 2025. First Oral Penem Available in the U.S.

Source: www.globenewswire.com
June 11, 2025 | 11:00:00
Category: News

Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.

MELBOURNE, Australia and INDIANAPOLIS, June 11, 2025 ( GLOBE NEWSWIRE ) -- Telix Pharmaceuticals Limited ( ASX: TLX, NASDAQ: TLX, "Telix", "the Company" ) today announces that its next-generation PSMA-PET imaging1 agent for prostate cancer, Gozellix® ( kit for the preparation of gallium-68 ( ...

Source: www.globenewswire.com
June 11, 2025 | 11:00:00
Category: News

Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers

WILMETTE, Ill. and HOUSTON, Texas, June 11, 2025 ( GLOBE NEWSWIRE ) -- Monopar Therapeutics Inc. ( "Monopar," the "Company," "us" and "our" ) ( Nasdaq: MNPR ) , a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, in ...

Source: www.globenewswire.com
June 11, 2025 | 11:00:00
Category: News

Baker Hughes Receives Award from Equinor to Industrialize Offshore Plug & Abandonment Operations in Oseberg East Field

HOUSTON and LONDON, June 11, 2025 ( GLOBE NEWSWIRE ) -- Baker Hughes ( NASDAQ: BKR ) , an energy technology company, will provide Equinor plug and abandonment ( P&A ) services in the Oseberg East field on Norway's continental shelf. Baker Hughes' Mature Assets Solutions team will lead the ...

Source: www.globenewswire.com
June 11, 2025 | 11:00:00
Category: News

Axsome Therapeutics Showcases Innovation in Sleep Medicine with Multiple Presentations for AXS-12 and Solriamfetol at SLEEP 2025

NEW YORK, June 11, 2025 ( GLOBE NEWSWIRE ) -- Axsome Therapeutics, Inc. ( NASDAQ: AXSM ) , a biopharmaceutical company leading a new era in the treatment of central nervous system ( CNS ) disorders, today announced seven presentations, including two featured oral plenary sessions, on AXS-12 and ...

Source: www.globenewswire.com
June 11, 2025 | 11:00:00
Category: News

Lottery.com To Increase Ownership Stake in Nook Holdings, UAE-Based Sports Incubator

DUBAI, United Arab Emirates, June 11, 2025 ( GLOBE NEWSWIRE ) -- Lottery.com Inc. ( NASDAQ: LTRY, LTRYW ) ( "Lottery.com" or "the Company" ) , a leading technology company transforming the intersection of gaming, sports and entertainment, announces the signing of an amended Stock Purchase ...

Source: www.globenewswire.com
June 11, 2025 | 11:00:00
Category: News

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress

SOUTH SAN FRANCISCO, Calif., June 11, 2025 ( GLOBE NEWSWIRE ) -- Corvus Pharmaceuticals, Inc. ( NASDAQ: CRVS ) , a clinical-stage biopharmaceutical company, today announced preclinical data highlighting the potential of soquelitinib to treat systemic sclerosis will be presented today in a poster ...

Source: www.globenewswire.com
June 11, 2025 | 11:00:00
Category: News

© Natavest 2025 - 2026